» Articles » PMID: 30571427

Severe Lesions Involving Cortical Cholinergic Pathways Predict Poorer Functional Outcome in Acute Ischemic Stroke

Overview
Journal Stroke
Date 2018 Dec 21
PMID 30571427
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background and Purpose- The aim of the study was to assess the effect of lesion severity in cortical cholinergic pathways in acute ischemic stroke patients on functional outcomes. Methods- The study sample consisted of 214 men (70.9%) and 88 women (29.1%) with acute ischemic stroke. We used the Cholinergic Pathways Hyperintensities Scale (CHIPS) to assess the severity of lesions in cortical cholinergic pathways using brain magnetic resonance imaging. The other magnetic resonance imaging parameters included infarction, white matter lesions, and medial temporal lobe atrophy. Functional outcome was assessed using the Lawton activities of daily living (ADL) scale at 3 and 6 months after the index stroke. We also assessed disability status using the modified Rankin Scale. Results- Univariate analysis showed that patients with poor functional outcomes were older, more likely to be men, had a higher National Institutes of Health Stroke Scale (NIHSS) score on admission, and had more frequent histories of previous stroke and infection complications. They also had significantly more frequent cortical infarcts, left subcortical infarcts, a larger infarct volume, more severe medial temporal lobe atrophy, and periventricular hyperintensities, and higher CHIPS scores. In the multiple regression analysis, model 1 showed that age and NIHSS score on admission were significant predictors of poor ADL at 3 months, with an R of 45.4% fitting the model. Age, NIHSS score on admission and stroke subtype were also significant predictors of poor ADL at 6 months, with an R of 37.9% fitting the model. In model 2, sex, previous stroke, NIHSS score on admission, right cortical infarcts, left subcortical infarcts and CHIPS score were significant predictors for poor ADL at 3 months, with an R of 53.5%. NIHSS score on admission, stroke subtype, and CHIPS score were significant predictors for poor ADL at 6 months, with an R of 40.2%. After adjustment for confounders, CHIPS score was also a significant predictor for poor modified Rankin Scale, both at 3 and 6 months. Even after removing patients with moderate-to-severe white matter lesions, higher CHIPS scores still correlated with poorer ADL and modified Rankin Scale both at both 3 and 6 months. Conclusions- In patients with acute ischemic stroke, cortical cholinergic pathways impairment is common, and the severity of lesions in the cortical cholinergic pathways may significantly predict a poorer functional outcome. Clinical Trial Registration- URL: http://www.chictr.org.cn/index.aspx . Unique identifier: ChiCTR1800014982.

Citing Articles

Clinical and imaging associations for non-ketotic hyperglycemic chorea: a case-control study.

Liang Z, Lu Z, Qu J, Chen Y Front Endocrinol (Lausanne). 2024; 14:1323942.

PMID: 38189042 PMC: 10769489. DOI: 10.3389/fendo.2023.1323942.


White matter hyperintensities in cholinergic pathways correlates of cognitive impairment in moyamoya disease.

Xu D, Yu X, Hu J, Yu Y, Wang L, Jiang B Eur Radiol. 2023; 34(7):4596-4606.

PMID: 38092950 DOI: 10.1007/s00330-023-10489-3.


Larger deep white matter hyperintensity volume correlates with more severe social behavioral changes in patients with subacute ischemic stroke.

Qu J, Hu H, Liu J, Zhou Y, Cheng W, Shi L Front Aging Neurosci. 2023; 15:1259690.

PMID: 38076539 PMC: 10702571. DOI: 10.3389/fnagi.2023.1259690.


Association between white matter hyperintensity volume and social functioning limitations among stroke survivors.

Chang F, Rost N, Manson J, Buring J, Rist P J Stroke Cerebrovasc Dis. 2022; 31(10):106720.

PMID: 36007263 PMC: 9509456. DOI: 10.1016/j.jstrokecerebrovasdis.2022.106720.


Right Cortical Infarction and a Reduction in Putamen Volume May Be Correlated with Empathy in Patients after Subacute Ischemic Stroke-A Multimodal Magnetic Resonance Imaging Study.

Qu J, Zhou Y, Liu J, Hu H, Cheng W, Lu Z J Clin Med. 2022; 11(15).

PMID: 35956096 PMC: 9369598. DOI: 10.3390/jcm11154479.


References
1.
Selden N, Gitelman D, Parrish T, Mesulam M . Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1999; 121 ( Pt 12):2249-57. DOI: 10.1093/brain/121.12.2249. View

2.
Kim H, Moon W, Han S . Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia. J Alzheimers Dis. 2013; 35(1):129-36. DOI: 10.3233/JAD-122320. View

3.
Kim K, Muller M, Bohnen N, Sarter M, Lustig C . Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson's disease patients with defined cholinergic losses. Neuroimage. 2017; 149:295-304. PMC: 5386784. DOI: 10.1016/j.neuroimage.2017.02.006. View

4.
Fukui T, Hieda S, Bocti C . Do lesions involving the cortical cholinergic pathways help or hinder efficacy of donepezil in patients with Alzheimer's disease?. Dement Geriatr Cogn Disord. 2006; 22(5-6):421-31. DOI: 10.1159/000095801. View

5.
Marsel Mesulam M . The cholinergic innervation of the human cerebral cortex. Prog Brain Res. 2003; 145:67-78. DOI: 10.1016/S0079-6123(03)45004-8. View